May 26, 2005 (Atlanta) — As the result of positive phase 3 trials, ropinirole (Requip) has been approved for the treatment of restless legs syndrome (RLS). The data presented here at the 2005 American ...
Restless leg syndrome (RLS) is often worse at nighttime. Some people may only have the symptoms at this time. Many with RLS also experience limb movements during sleep. As many as 80% of people with ...
Treatment of restless legs syndrome (RLS) usually involves dopamine agonists, which are approved for treatment of RLS in most countries; α-2-δ ligands, such as gabapentin enacarbil and pregabalin, are ...
PLEASANTON, Calif., April 19, 2023 /PRNewswire/ -- Noctrix Health announced that the U.S. Food and Drug Administration (FDA) has granted its De Novo request for the NTX100 Tonic Motor Activation ...
Restless legs syndrome (RLS) is a sleep disorder that causes a feeling of heaviness and discomfort in the legs, usually after going to bed. Stretching or moving the legs usually helps. It may also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results